As of March 31, 2024, we had $31.3 million in cash and cash equivalents.
Outlook: The company said, that based on our research and development plans and our timing expectations related to the progress of our programs, it expects that their existing cash and cash equivalents will enable them to fund our operating expenses and capital expenditure requirements through the fourth quarter of 2024.